SBIR/STTR Research Award

RAPID FLUOROMETRIC ASSAY OF HIV-INDUCED CELL FUSION

Award identifier c34898f3d51e90ee861c7b4d630284dab008a9dab0b1bf3204e2eea278240aa4Awarding agency Department of Health and Human Services

Award amount

$437,296

Program and phase

SBIR · Phase II

Award year

1994

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
PROGENICS PHARMACEUTICALS, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
YLYKVRPCTCR3
Solicitation number
Not reported
Topic code
Not reported

Research abstract

CELLS WHICH EXPRESS GP120/GP41, THE HIV-1 ENVELOPE GLYCOPROTEIN, CAN FUSE WITH CELLS EXPRESSINGCD4, THE HIV RECEPTOR, TO FORM MULTI-NUCLEATED GIANT CELLS OF SYNCYTIA. SUCH CELL-TO-CELL FUSION APPEARS TO BE A MECHANISM FOR VIRUS TRANSMISSION, AS WELL AS A PRIMARY CAUSE OF CELL DEATH, AND MAY PLAY AN IMPORTANT ROLE IN THE DEVELOPMENT OF AIDS. CURRENT METHODS FOR MEASURING HIV-INDUCED CELL FUSION ARE BASED ON THE PRDUCTION OF SYNCYTIA IN CD4+ CELLS INFECTEDWITH HIV OR IN CELLS EXPRESSING ENV USING A TRANSIENT EXPRESSION SYSTEM. SUCH ASSAYS TYPICALLYREQUIRE SEVERAL DAYS, OFFER VARIABLE RESULTS, AND HAVE A VISUAL READOUT WHICH IS BOTH LABOR- INTENSIVE AND SUBJECTIVE. OUR FIRST GOAL IS TO DEVELOP A REPRODUCIBLE, VIRUS-FREE CELL FUSION ASSAY BASED ON SYNCYTIUM FORMATION BETWEEN CELLS STABLE EXPRESSING HIV-1 GP120/GP41 AND CD4. OUR SECOND GOAL IS TO DEMONSTRATE THAT FUSION BETWEEN THESE CELLS CAN BE ASSAYED RAPIDLY AND WITH SPECIFICITY USING THE FLUORESCENCE DEQUENCHING (FDQ) METHOD. SUCH AN ASSAY WOULD BE INVALUABLE FOR DETECTING MEMBRANE FUSION IN REAL-TIME AND FOR ACCURATELY MEASURING FUSION KINETICS. IN PHASE II, THE FDQ FUSION ASSAY WOULD BE USED IN BASIC RESEARCH STUDIES OF HIV- INDUCED CELL FUSION, INCLUDING THE IDENTIFICATION OF MOLECULES, IN ADDITION TO CD4 AND GP120/ GP41, WHICH ARE INVOLVED IN MEMBRANE FUSION. BY ESTABLISHING NEW CELL LINES WITH ENV GENES DERIVED FROM DIFFERENT STRAINS OF HIV-1, THE ASSAY WOULD BE USEFUL IN EXAMINING THE FUSOGENIC PROPERTIES OF DIFFERENT ISOLATES. SEVERAL APPLICATIONS OF THIS ASSAY WOULD BE INVESTIGATED, INCLUDING THE DEVELOPMENT OF NEW CLINICAL MARKERS FOR HIV DISEASE, SUCH AS THE PRESENCE OF ANTI-SYNCYTIAL ANTIBODIES AND THE APPEARANCE OF SYNCYTIUM-INDUCING ISOLATES. FINALLY, THE ASSAY WOULD SERVE AS A MODEL OF VIRUS-CELL FUSION, PERMITTING THE IDENTIFICATION AND DEVELOPMENT OF NOVEL ANTI-FUSION COMPOUNDS AND MONOCLONAL NEUTRALIZING ANTIBODIES WHICH INHIBIT VIRAL ENTRY.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

39 SBIR/STTR records share this UEI (1990–2007). Reported award amounts total $29,853,777. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.